Irene Andia Biraro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irene Andia Biraro has a total of 178 co-authors. Here are the top co-authors by number of shared publications:
- Stephen Cose
Medical Research Council/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine Uganda Research Unit, Entebbe, Uganda
10 shared publications - Alison M. Elliott
MRC/UVRI and LSHTM Uganda Research Unit, Entebbe, Uganda
8 shared publications - Felix Bongomin
Department of Medical Microbiology and Immunology, Gulu University, Gulu, Uganda
7 shared publications - Joseph Baruch Baluku
Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda
6 shared publications - Davis Kibirige
Tuberculosis and comorbidities research consortium
5 shared publications - Damalie Nakanjako
Infectious Diseases Institute, Makerere University College of Health Sciences
4 shared publications
Latest Publications
- Open Access
- 25 April 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (5)
Adjunct Diagnostic Accuracy of Antigen-specific Interleukin-2 for Latent Tuberculosis Infection in Pregnancy
Background: Pregnancy modulates immune responses against Mycobacterium tuberculosis (Mtb) infection. Cytokines, including interleukin-2 (IL-2), play a crucial role in Mtb containment, mainly by inducing the proliferation of T cells. However, the role of IL-2 in latent tuberculosis (TB) infection (LTBI) screening has not been completely explored. We, therefore, evaluated the diagnostic accuracy and optimal cutoff value (OCV) of IL-2 as a potential adjunct biomarker for screening LTBI during pregnancy. Methods: We enrolled pregnant women without previous active TB at Kawempe National Referral Hospital, Uganda, in 2020. We tested for LTBI using the QuantiFERON-TB Gold-Plus assay. Blood in quantiFERON blood collection tubes was stimulated with Mtb peptides of ESAT-6 and CFP-10 and following incubation, IL-2 culture supernatant levels were measured in an 11-plex Luminex assay using the Luminex® 100/200™ System with xPONENT® 3.1 software. LTBI positivity was defined as an IFN-γ concentration ≥0.35 IU/mL (calculated as TB1/TB2-Nil). A receiver operator characteristic curve was plotted to assess the diagnostic performance of Mtb-specific IL-2 culture supernatants using STATA 18.0. The OCV was determined using the Youden index, considering sensitivity and specificity. Results: Of 159 participants, the median gestational age was 26.1 (IQR: 20.0–31.6) weeks, 8.2% (n = 13) had HIV, and 10.1% (n = 16) were recent TB contacts. Overall, 79 (49.7%) had LTBI. Mtb-specific IL-2 levels were significantly higher in LTBI than in the non-LTBI group (847.9 (418.2–1309.1) versus 147.73 (100.38–207.19) pg/mL, P < .001). IL-2 achieved an AUC of 0.88 (95% CI: 0.82–0.93), with 76% sensitivity and 96% specificity. IFN-γ showed an AUC of 0.83 (95% CI: 0.76–0.90), with 78% sensitivity and 90% specificity. The combined IL-2 + IFN-γ response yielded the highest accuracy, with an AUC of 0.89 (95% CI: 0.83–0.94), 77% sensitivity, and 95% specificity. Conclusions: Mtb-specific IL-2 culture supernatant levels showed good discriminatory power for LTBI detection in pregnancy, comparable to IFN-γ, with the combined IL-2+ IFN-γ response yielding the highest accuracy. These findings support the potential utility of IL-2, alone or with IFN-γ, as an adjunct biomarker for LTBI screening in pregnant women, warranting further validation in larger, diverse cohorts.
- 25 April 2026
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 13 (5)
Open AccessAdjunct Diagnostic Accuracy of Antigen-specific Interleukin-2 for Latent Tuberculosis Infection in Pregnancy
Background: Pregnancy modulates immune responses against Mycobacterium tuberculosis (Mtb) infection. Cytokines, including interleukin-2 (IL-2), play a crucial role in Mtb containment, mainly by inducing the proliferation of T cells. However, the role of IL-2 in latent tuberculosis (TB) infection (LTBI) screening has not been completely explored. We, therefore, evaluated the diagnostic accuracy and optimal cutoff value (OCV) of IL-2 as a potential adjunct biomarker for screening LTBI during pregnancy. Methods: We enrolled pregnant women without previous active TB at Kawempe National Referral Hospital, Uganda, in 2020. We tested for LTBI using the QuantiFERON-TB Gold-Plus assay. Blood in quantiFERON blood collection tubes was stimulated with Mtb peptides of ESAT-6 and CFP-10 and following incubation, IL-2 culture supernatant levels were measured in an 11-plex Luminex assay using the Luminex® 100/200™ System with xPONENT® 3.1 software. LTBI positivity was defined as an IFN-γ concentration ≥0.35 IU/mL (calculated as TB1/TB2-Nil). A receiver operator characteristic curve was plotted to assess the diagnostic performance of Mtb-specific IL-2 culture supernatants using STATA 18.0. The OCV was determined using the Youden index, considering sensitivity and specificity. Results: Of 159 participants, the median gestational age was 26.1 (IQR: 20.0–31.6) weeks, 8.2% (n = 13) had HIV, and 10.1% (n = 16) were recent TB contacts. Overall, 79 (49.7%) had LTBI. Mtb-specific IL-2 levels were significantly higher in LTBI than in the non-LTBI group (847.9 (418.2–1309.1) versus 147.73 (100.38–207.19) pg/mL, P < .001). IL-2 achieved an AUC of 0.88 (95% CI: 0.82–0.93), with 76% sensitivity and 96% specificity. IFN-γ showed an AUC of 0.83 (95% CI: 0.76–0.90), with 78% sensitivity and 90% specificity. The combined IL-2 + IFN-γ response yielded the highest accuracy, with an AUC of 0.89 (95% CI: 0.83–0.94), 77% sensitivity, and 95% specificity. Conclusions: Mtb-specific IL-2 culture supernatant levels showed good discriminatory power for LTBI detection in pregnancy, comparable to IFN-γ, with the combined IL-2+ IFN-γ response yielding the highest accuracy. These findings support the potential utility of IL-2, alone or with IFN-γ, as an adjunct biomarker for LTBI screening in pregnant women, warranting further validation in larger, diverse cohorts.
- Open Access
The impact of tuberculosis and its treatment on the lung and gut microbiota: A global systematic review, meta-analysis, and amplicon-based metagenomic meta-analysis
Background: Tuberculosis (TB) remains the leading cause of bacterial disease-related deaths worldwide. Historically, the Koch’s single-causative-agent model has shaped diagnostics, treatment, and prevention. However, metagenomic studies have unveiled the presence of a lung microbiome, which is disrupted by TB and its orally administered treatment, with downstream effects on the gut microbiome. These changes may hold diagnostic, prognostic, and control potential once better understood. Here, we systematically analyze 38 studies with 3,394 individuals with TB and health controls to assess global insights on the impact of TB and its treatment on lung and gut microbiome diversity, structure, and composition. A meta-analysis with 24 studies estimates this effect size, while a patient-level amplicon metagenomic meta-analysis with 1617 individuals with 1.3 billion reads validates these associations. This study followed PRISMA guidelines and a pre-registered PROSPERO protocol (CRD42022329763). Results: The systematic review reveals no global consensus on TB’s impact on the lung microbial diversity, though most studies report reduced diversity. However, we estimate a 0.14–0.41 overall reduction in lung and gut diversity. Patient-level lung diversity analysis showed no significant differences overall (Shannon index), though TB was associated with reduced diversity in China, but not in South Africa. In contrast, in the gut TB was associated with higher diversity in most countries. The TB diagnostic value of the microbiome remains uncertain, as disease status accounts for only 0.8–9% of lung and 1.8–9% of gut microbiota variation. However, lung depletion of Prevotella, Neisseria, Veillonella, Haemophilus, Fusobacterium, Pseudomonas, Streptococcus, Porphyromonas , and Treponema , along with gut depletion of Prevotella, Ruminococcus, Faecalibacterium, Clostridium, Roseburia, Rothia, Eubacterium, and Escherichia . TB treatment is associated with a reduction in diversity of both lung and gut. Conclusion: TB is generally linked to reduced microbial diversity in the lung, but not gut. In contrast, treatment consistently reduces diversity in both, depleting key core genera. These findings underscore the exploitable potential of the gut–lung axis to improve TB diagnostics and prognosis.
Open AccessThe impact of tuberculosis and its treatment on the lung and gut microbiota: A global systematic review, meta-analysis, and amplicon-based metagenomic meta-analysis
Background: Tuberculosis (TB) remains the leading cause of bacterial disease-related deaths worldwide. Historically, the Koch’s single-causative-agent model has shaped diagnostics, treatment, and prevention. However, metagenomic studies have unveiled the presence of a lung microbiome, which is disrupted by TB and its orally administered treatment, with downstream effects on the gut microbiome. These changes may hold diagnostic, prognostic, and control potential once better understood. Here, we systematically analyze 38 studies with 3,394 individuals with TB and health controls to assess global insights on the impact of TB and its treatment on lung and gut microbiome diversity, structure, and composition. A meta-analysis with 24 studies estimates this effect size, while a patient-level amplicon metagenomic meta-analysis with 1617 individuals with 1.3 billion reads validates these associations. This study followed PRISMA guidelines and a pre-registered PROSPERO protocol (CRD42022329763). Results: The systematic review reveals no global consensus on TB’s impact on the lung microbial diversity, though most studies report reduced diversity. However, we estimate a 0.14–0.41 overall reduction in lung and gut diversity. Patient-level lung diversity analysis showed no significant differences overall (Shannon index), though TB was associated with reduced diversity in China, but not in South Africa. In contrast, in the gut TB was associated with higher diversity in most countries. The TB diagnostic value of the microbiome remains uncertain, as disease status accounts for only 0.8–9% of lung and 1.8–9% of gut microbiota variation. However, lung depletion of Prevotella, Neisseria, Veillonella, Haemophilus, Fusobacterium, Pseudomonas, Streptococcus, Porphyromonas , and Treponema , along with gut depletion of Prevotella, Ruminococcus, Faecalibacterium, Clostridium, Roseburia, Rothia, Eubacterium, and Escherichia . TB treatment is associated with a reduction in diversity of both lung and gut. Conclusion: TB is generally linked to reduced microbial diversity in the lung, but not gut. In contrast, treatment consistently reduces diversity in both, depleting key core genera. These findings underscore the exploitable potential of the gut–lung axis to improve TB diagnostics and prognosis.
- Open Access
- 21 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 154
Vitamin D binding protein rs7041 and rs4588 gene polymorphisms in Ugandan tuberculosis patients and household contacts: A pilot study
Background Tuberculosis remains a significant global public health concern. Genetic variants influence the distribution of vitamin D in circulation, leading to vitamin D deficiency. The two extensively studied non-synonymous D-binding protein nucleotide polymorphisms rs7041 and rs4588 were found in different populations. These polymorphisms result into three different genotypes, Gc1F (rs7041(A)- rs4588(G)), Gc1S (rs7041(C)- rs4588(G)) and Gc2 (rs7041(A)- rs4588(T)). These genotypes have configurational changes that differ and therefore cause variation in the binding affinity of the vitamin D metabolite. This study aimed to compare the frequency distribution of vitamin D binding protein gene polymorphisms in patients with active Ugandan tuberculosis, individuals with latent tuberculosis infection, and those with no tuberculosis infection. Methods This pilot studyselected 102 samples, including 52 active tuberculosis patients, 23 latent tuberculosis individuals, and 27 individuals without tuberculosis infection, from a previous cross-sectional study. Vitamin D binding protein rs7041 and rs4588 SNPs were genotyped using Polymerase Chain Reaction and Sanger sequencing. Vitamin D binding protein gene polymorphisms were identified using BioEdit software. 7.2 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) Results This study revealed no significant differences in DBP genetic polymorphisms among the study groups. The frequency distribution of the DBP gene has been reported to be 97% Gc1F, 2% Gc2, and 1% Gc1S. The frequency distribution among patients with TB was 96.2% for Gc1F, 0% for Gc1F, and 3.8% for Gc2. Among the LTBI cases, 95.7% were Gc1F, 4.3% were Gc1S, and 0%were Gc2. The Hardy-Weinberg equilibrium analysis was in equilibrium, D’= 0. P=0.2 Conclusions The Gc1F genotype was predominantly found in the study population, with no difference in the frequency distribution according to TB status.
- 21 May 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 154
Open AccessVitamin D binding protein rs7041 and rs4588 gene polymorphisms in Ugandan tuberculosis patients and household contacts: A pilot study
Background Tuberculosis remains a significant global public health concern. Genetic variants influence the distribution of vitamin D in circulation, leading to vitamin D deficiency. The two extensively studied non-synonymous D-binding protein nucleotide polymorphisms rs7041 and rs4588 were found in different populations. These polymorphisms result into three different genotypes, Gc1F (rs7041(A)- rs4588(G)), Gc1S (rs7041(C)- rs4588(G)) and Gc2 (rs7041(A)- rs4588(T)). These genotypes have configurational changes that differ and therefore cause variation in the binding affinity of the vitamin D metabolite. This study aimed to compare the frequency distribution of vitamin D binding protein gene polymorphisms in patients with active Ugandan tuberculosis, individuals with latent tuberculosis infection, and those with no tuberculosis infection. Methods This pilot studyselected 102 samples, including 52 active tuberculosis patients, 23 latent tuberculosis individuals, and 27 individuals without tuberculosis infection, from a previous cross-sectional study. Vitamin D binding protein rs7041 and rs4588 SNPs were genotyped using Polymerase Chain Reaction and Sanger sequencing. Vitamin D binding protein gene polymorphisms were identified using BioEdit software. 7.2 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) Results This study revealed no significant differences in DBP genetic polymorphisms among the study groups. The frequency distribution of the DBP gene has been reported to be 97% Gc1F, 2% Gc2, and 1% Gc1S. The frequency distribution among patients with TB was 96.2% for Gc1F, 0% for Gc1F, and 3.8% for Gc2. Among the LTBI cases, 95.7% were Gc1F, 4.3% were Gc1S, and 0%were Gc2. The Hardy-Weinberg equilibrium analysis was in equilibrium, D’= 0. P=0.2 Conclusions The Gc1F genotype was predominantly found in the study population, with no difference in the frequency distribution according to TB status.
- Open Access
- 4 February 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 154
Vitamin D binding protein gene polymorphisms in Ugandan tuberculosis patients and household contacts: A pilot study
Background Tuberculosis remains a significant global public health concern. Genetic variants influence the distribution of vitamin D in circulation, leading to vitamin D deficiency. The two extensively studied non-synonymous D-binding protein nucleotide polymorphisms rs7041 and rs4588 were found in different populations. This study aimedto compare the frequency distribution of vitamin D binding protein gene polymorphisms in patients with active Ugandan tuberculosis, individuals with latent tuberculosis infection, and those with no tuberculosis infection. Methods This pilot studyselected 102 samples, including 52 active tuberculosis patients, 23 latent tuberculosis individuals, and 27 individuals without tuberculosis infection, from a previous cross-sectional study. Vitamin D binding protein genesrs7041 and rs4588 were genotyped usingPolymerase Chain reaction and Sanger sequencing. vitamin D binding protein gene polymorphisms were identified using BioEditsoftware. 7.2 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) Results This study revealed no significant differences in DBP genetic polymorphisms among the study groups. The frequency distribution of the DBP gene has been reported to be 97% Gc1F, 2% Gc2, and 1% Gc1S. The frequency distribution among patients with TB was 96.2% for Gc1F, 0% for Gc1F, and 3.8% for Gc2. Among the LTBI cases, 95.7% were Gc1F, 4.3% were Gc1S, and 0%were Gc2. The Hardy-Weinberg equilibrium analysis was in equilibrium, D’= 0. P=0.2 Conclusions The Gc1F genotype was predominantly found in the study population, with no difference in the frequency distribution according to TB status. However, minor alleles appear to be associated withan increased risk of active and latent TB. Therefore, we recommend larger studies in different populations to elucidate the functional significance of these minor alleles and their roles in TB pathogenesis.
- 4 February 2025
- Published by F1000 Research Ltd in F1000Research
- Vol. 14, 154
Open AccessVitamin D binding protein gene polymorphisms in Ugandan tuberculosis patients and household contacts: A pilot study
Background Tuberculosis remains a significant global public health concern. Genetic variants influence the distribution of vitamin D in circulation, leading to vitamin D deficiency. The two extensively studied non-synonymous D-binding protein nucleotide polymorphisms rs7041 and rs4588 were found in different populations. This study aimedto compare the frequency distribution of vitamin D binding protein gene polymorphisms in patients with active Ugandan tuberculosis, individuals with latent tuberculosis infection, and those with no tuberculosis infection. Methods This pilot studyselected 102 samples, including 52 active tuberculosis patients, 23 latent tuberculosis individuals, and 27 individuals without tuberculosis infection, from a previous cross-sectional study. Vitamin D binding protein genesrs7041 and rs4588 were genotyped usingPolymerase Chain reaction and Sanger sequencing. vitamin D binding protein gene polymorphisms were identified using BioEditsoftware. 7.2 (http://www.mbio.ncsu.edu/BioEdit/bioedit.html) Results This study revealed no significant differences in DBP genetic polymorphisms among the study groups. The frequency distribution of the DBP gene has been reported to be 97% Gc1F, 2% Gc2, and 1% Gc1S. The frequency distribution among patients with TB was 96.2% for Gc1F, 0% for Gc1F, and 3.8% for Gc2. Among the LTBI cases, 95.7% were Gc1F, 4.3% were Gc1S, and 0%were Gc2. The Hardy-Weinberg equilibrium analysis was in equilibrium, D’= 0. P=0.2 Conclusions The Gc1F genotype was predominantly found in the study population, with no difference in the frequency distribution according to TB status. However, minor alleles appear to be associated withan increased risk of active and latent TB. Therefore, we recommend larger studies in different populations to elucidate the functional significance of these minor alleles and their roles in TB pathogenesis.
- Open Access
Mycobacterium tuberculosis -specific cytokine responses of infants born to mothers with active tuberculosis in Uganda
Background: Immunizing infants with various vaccines, including Bacillus Calmette–Guérin (BCG), Diphtheria-Pertusis-Tetanus (DPT), and measles, aims to enhance immunity. In instances where vaccine responses have been reported to be compromised, individuals are prone to infection. The BCG vaccine, for example, induces strong type 1 immune responses, particularly interferon-gamma (IFN-γ) expression, that are essential for protection against Mycobacterium tuberculosis ( Mtb) . However, there is scanty evidence on whether this effect is established or sustained when infants are exposed to Mtb either in utero or after birth. We compared TB-specific cytokine responses for IFN-γ, interleukin (IL)-2 (IL-2), tumour necrosis factor-alpha (TNF-α), IL-17A, and Granulocyte-macrophage colony-stimulating factor (GM-CSF) using supernatants harvested from QFT-Plus Blood Collection Tubes. Methods: This cross-sectional study compared 22 infants born to mothers with bacteriologically confirmed active tuberculosis (TB), defined as TB exposed or cases, to 20 infants born to mothers without active TB, defined as TB non-exposed or controls. Plasma harvested from the QFT-plus tubes (TB1 and TB2) was used to perform a 5-plex Luminex assay using the LX 100/200 Luminex machine and measured in pg/mL. Data was analysed using R (v.4.4.1). The Mann-Whitney U test was used to determine statistical significance at a p-value less than 0.05 and a 95% confidence interval. Data was expressed as median and interquartile ranges (IQR). Results: TB-exposed infants showed IFNγ responses were slightly higher among TB-exposed infants compared to non-exposed (Medians (IQR): 15.49 (14.58-16.49) versus 14.96 (14.60-16.60), p=0.68, respectively. There was a strong expression of total IL-17A among TB-exposed compared to non-exposed 11.91 (10.89-13.50) versus 10.69 (10.17-11.64), p=0.035. We observed no differences in IL-2, TNF, and GM-CSF responses. Conclusion: TB exposure among infants slightly alters their Mtb -specific cytokine responses, especially IL-17A cytokine responses. This suggests possible ongoing Mtb infection among TB-exposed infants. Follow-up studies of such infants are necessary to assess their risk of future TB infection and disease and the potential need for TB chemoprophylaxis.
Open AccessMycobacterium tuberculosis -specific cytokine responses of infants born to mothers with active tuberculosis in Uganda
Background: Immunizing infants with various vaccines, including Bacillus Calmette–Guérin (BCG), Diphtheria-Pertusis-Tetanus (DPT), and measles, aims to enhance immunity. In instances where vaccine responses have been reported to be compromised, individuals are prone to infection. The BCG vaccine, for example, induces strong type 1 immune responses, particularly interferon-gamma (IFN-γ) expression, that are essential for protection against Mycobacterium tuberculosis ( Mtb) . However, there is scanty evidence on whether this effect is established or sustained when infants are exposed to Mtb either in utero or after birth. We compared TB-specific cytokine responses for IFN-γ, interleukin (IL)-2 (IL-2), tumour necrosis factor-alpha (TNF-α), IL-17A, and Granulocyte-macrophage colony-stimulating factor (GM-CSF) using supernatants harvested from QFT-Plus Blood Collection Tubes. Methods: This cross-sectional study compared 22 infants born to mothers with bacteriologically confirmed active tuberculosis (TB), defined as TB exposed or cases, to 20 infants born to mothers without active TB, defined as TB non-exposed or controls. Plasma harvested from the QFT-plus tubes (TB1 and TB2) was used to perform a 5-plex Luminex assay using the LX 100/200 Luminex machine and measured in pg/mL. Data was analysed using R (v.4.4.1). The Mann-Whitney U test was used to determine statistical significance at a p-value less than 0.05 and a 95% confidence interval. Data was expressed as median and interquartile ranges (IQR). Results: TB-exposed infants showed IFNγ responses were slightly higher among TB-exposed infants compared to non-exposed (Medians (IQR): 15.49 (14.58-16.49) versus 14.96 (14.60-16.60), p=0.68, respectively. There was a strong expression of total IL-17A among TB-exposed compared to non-exposed 11.91 (10.89-13.50) versus 10.69 (10.17-11.64), p=0.035. We observed no differences in IL-2, TNF, and GM-CSF responses. Conclusion: TB exposure among infants slightly alters their Mtb -specific cytokine responses, especially IL-17A cytokine responses. This suggests possible ongoing Mtb infection among TB-exposed infants. Follow-up studies of such infants are necessary to assess their risk of future TB infection and disease and the potential need for TB chemoprophylaxis.
- Open Access
Reduced Bacille Calmette-Guérin -specific IgG titres among babies born to mothers with Active Tuberculosis Disease in Uganda
Background Babies born to mothers with active tuberculosis disease (ATB) are at risk of poor clinical outcomes such as low birth weight and perinatal mortality. However, little is known about the influence of maternal ATB exposure on their vaccine responses during infancy. The study aimed to explore how maternal ATB affects infants’ vaccine responses, hypothesising reduced responses to BCG and other infant vaccines. Methods This was a case-control study with a longitudinal component of babies born to mothers with bacteriologically confirmed ATB (cases) and babies born to mothers without ATB (controls) carried out between September 2021 and June 2022. Quantitative BCG, diphtheria, tetanus, and measles-specific IgG ELISA assays were performed on infant plasma harvested from lithium-heparin blood collected on first encounter after birth (0), at 3, 6, and 9 months. We used prism v10.1.2, Mixed-effects modelling, and Tukey’s multiple comparison testing to determine mean differences (MD) between the cases and controls at all time points. Results Infants cases had reduced IgG titres to BCG at baseline compared to the controls (p=0.04), with a mean of 125.8/141.1 IU/mL, respectively. This difference was, however, not sustained at the other time points. Similarly, we demonstrated strong trends of reduced responses to tetanus, diphtheria, and measles vaccines among infant cases at baseline and three-month time points and weakly at months six and nine. The mean titres for tetanus at baseline and 3 months for cases versus controls are 1.744/2.917 IU/mL and 1.716/2.344 IU/mL (pConclusion We have demonstrated that maternal TB disease influences vaccine responses to BCG and other infant vaccines. This has implications for increased risk of childhood TB and other preventable diseases.
Open AccessReduced Bacille Calmette-Guérin -specific IgG titres among babies born to mothers with Active Tuberculosis Disease in Uganda
Background Babies born to mothers with active tuberculosis disease (ATB) are at risk of poor clinical outcomes such as low birth weight and perinatal mortality. However, little is known about the influence of maternal ATB exposure on their vaccine responses during infancy. The study aimed to explore how maternal ATB affects infants’ vaccine responses, hypothesising reduced responses to BCG and other infant vaccines. Methods This was a case-control study with a longitudinal component of babies born to mothers with bacteriologically confirmed ATB (cases) and babies born to mothers without ATB (controls) carried out between September 2021 and June 2022. Quantitative BCG, diphtheria, tetanus, and measles-specific IgG ELISA assays were performed on infant plasma harvested from lithium-heparin blood collected on first encounter after birth (0), at 3, 6, and 9 months. We used prism v10.1.2, Mixed-effects modelling, and Tukey’s multiple comparison testing to determine mean differences (MD) between the cases and controls at all time points. Results Infants cases had reduced IgG titres to BCG at baseline compared to the controls (p=0.04), with a mean of 125.8/141.1 IU/mL, respectively. This difference was, however, not sustained at the other time points. Similarly, we demonstrated strong trends of reduced responses to tetanus, diphtheria, and measles vaccines among infant cases at baseline and three-month time points and weakly at months six and nine. The mean titres for tetanus at baseline and 3 months for cases versus controls are 1.744/2.917 IU/mL and 1.716/2.344 IU/mL (pConclusion We have demonstrated that maternal TB disease influences vaccine responses to BCG and other infant vaccines. This has implications for increased risk of childhood TB and other preventable diseases.
- Open Access
- 23 January 2024
- Published by Wiley in Disease Markers
- Vol. 2024, 1-6
Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Distinguishing Lung Cancer in People with HIV
Objective. The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) demonstrate good diagnostic accuracy in distinguishing lung cancer patients from healthy individuals, primarily in HIV-negative populations. We determined the sensitivity (Se), specificity (Sp), and area under the curve (AUC) of the NLR and PLR in discriminating between people living with HIV (PLWH) with and without lung cancer. Methods. This is a comparative analysis of secondary data. Cases were PLWH with lung cancer from a retrospective cohort treated at the Uganda Cancer Institute. Controls were unmatched PLWH without lung cancer who were randomly selected from three HIV clinics in Uganda. Se, Sp, and AUC analysis and determination of optimal cutoffs were performed using receiver operating characteristic (ROC) curves. Results. Of 115 PLWH (18 cases and 97 controls), 83 (72.2%) were female, 110 (95.7) were on ART, and the median (IQR) age was 46 (38–51) years. The median (IQR) NLR was higher among cases than controls (3.53 (3.14–7.71) vs. 0.92 (0.67–1.09), ). Similarly, the PLR was higher among cases than controls (237.5 (177.8–361.6) vs. 123.6 (100.6–155.4), ). At a cutoff of 2.44, the respective Se, Sp, and AUC of the NLR were 87.5% (95% CI: 61.7%–98.4%), 100% (95% CI: 96.2%–100%), and 0.94 (95% CI: 0.85–1.00, ). Similarly, the respective Se, Sp, and AUC for the PLR were 75% (95% CI: 47.6%–92.7%), 87.2% (95% CI: 78.8%–93.2%), and 0.81 (95% CI: 0.70–0.93, ) at a cutoff of 196.3. Conclusion. The NLR and PLR discriminated PLWH with and without lung cancer and could be useful in PLWH with respiratory symptoms in whom lung cancer can easily be misdiagnosed as other lung pathology.
- 23 January 2024
- Published by Wiley in Disease Markers
- Vol. 2024, 1-6
Open AccessNeutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Distinguishing Lung Cancer in People with HIV
Objective. The neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR) demonstrate good diagnostic accuracy in distinguishing lung cancer patients from healthy individuals, primarily in HIV-negative populations. We determined the sensitivity (Se), specificity (Sp), and area under the curve (AUC) of the NLR and PLR in discriminating between people living with HIV (PLWH) with and without lung cancer. Methods. This is a comparative analysis of secondary data. Cases were PLWH with lung cancer from a retrospective cohort treated at the Uganda Cancer Institute. Controls were unmatched PLWH without lung cancer who were randomly selected from three HIV clinics in Uganda. Se, Sp, and AUC analysis and determination of optimal cutoffs were performed using receiver operating characteristic (ROC) curves. Results. Of 115 PLWH (18 cases and 97 controls), 83 (72.2%) were female, 110 (95.7) were on ART, and the median (IQR) age was 46 (38–51) years. The median (IQR) NLR was higher among cases than controls (3.53 (3.14–7.71) vs. 0.92 (0.67–1.09), ). Similarly, the PLR was higher among cases than controls (237.5 (177.8–361.6) vs. 123.6 (100.6–155.4), ). At a cutoff of 2.44, the respective Se, Sp, and AUC of the NLR were 87.5% (95% CI: 61.7%–98.4%), 100% (95% CI: 96.2%–100%), and 0.94 (95% CI: 0.85–1.00, ). Similarly, the respective Se, Sp, and AUC for the PLR were 75% (95% CI: 47.6%–92.7%), 87.2% (95% CI: 78.8%–93.2%), and 0.81 (95% CI: 0.70–0.93, ) at a cutoff of 196.3. Conclusion. The NLR and PLR discriminated PLWH with and without lung cancer and could be useful in PLWH with respiratory symptoms in whom lung cancer can easily be misdiagnosed as other lung pathology.
- Open Access
- 25 May 2023
- Published by Springer Nature in AIDS and Behavior
- Vol. 27 (11) , 3745-3754
The Effect of COVID-19 Restrictions on General and HIV Positive Inpatient Admissions and Treatment Outcomes: An Uncontrolled Before-and-after Study at a Ugandan Tertiary Hospital
Measures to contain the Corona Virus Disease 2019 (COVID-19) pandemic curtailed access to prevention and treatment services for endemic infectious diseases like HIV. We used an uncontrolled before-and-after study design to compare general and HIV positive (HIV+) inpatient outcomes at a tertiary hospital in Uganda, using electronic records of medical inpatients. Data was downloaded, cleaned in Microsoft Excel, and exported to STATA for analysis. We determined the difference in number of admissions and median length of hospital stay using Mann-Whitney U test; and difference in median survival and incidence rates of mortality using Kaplan – Meier statistics, between the pre- and peri-COVID-19 groups. Of 7506 patients admitted to Kiruddu NRH, 50.8% (3812) were female and 18.7% (1,401) were aged 31–40 years, and 18.8% (1,411) were HIV+. Overall, 24.6% (1849) died. Total admissions were lower (2192 vs. 5314 patients), overall mortality rate higher (41.8% vs. 17.6%, p < 0.01), median length of hospital stay longer (6 vs. 4 days, p < 0.01) and median survival shorter (11 vs. 20 days, Chi-square = 252.05, p < 0.01) in the peri- than in pre-COVID-19 period. The adjusted hazard ratio (aHR) of death was 2.08 (95% CI: 1.85–2.23, p < 0.01) in the peri- compared to the pre-COVID-19 period. These differences were more pronounced in HIV + patients. Compared to pre-COVID-19, the peri-COVID-19 period registered lower inpatient admissions but poorer treatment outcomes for general and HIV + inpatients. Emerging epidemic responses should minimize disruption to inpatient care, especially for HIV + individuals.
- 25 May 2023
- Published by Springer Nature in AIDS and Behavior
- Vol. 27 (11) , 3745-3754
Open AccessThe Effect of COVID-19 Restrictions on General and HIV Positive Inpatient Admissions and Treatment Outcomes: An Uncontrolled Before-and-after Study at a Ugandan Tertiary Hospital
Measures to contain the Corona Virus Disease 2019 (COVID-19) pandemic curtailed access to prevention and treatment services for endemic infectious diseases like HIV. We used an uncontrolled before-and-after study design to compare general and HIV positive (HIV+) inpatient outcomes at a tertiary hospital in Uganda, using electronic records of medical inpatients. Data was downloaded, cleaned in Microsoft Excel, and exported to STATA for analysis. We determined the difference in number of admissions and median length of hospital stay using Mann-Whitney U test; and difference in median survival and incidence rates of mortality using Kaplan – Meier statistics, between the pre- and peri-COVID-19 groups. Of 7506 patients admitted to Kiruddu NRH, 50.8% (3812) were female and 18.7% (1,401) were aged 31–40 years, and 18.8% (1,411) were HIV+. Overall, 24.6% (1849) died. Total admissions were lower (2192 vs. 5314 patients), overall mortality rate higher (41.8% vs. 17.6%, p < 0.01), median length of hospital stay longer (6 vs. 4 days, p < 0.01) and median survival shorter (11 vs. 20 days, Chi-square = 252.05, p < 0.01) in the peri- than in pre-COVID-19 period. The adjusted hazard ratio (aHR) of death was 2.08 (95% CI: 1.85–2.23, p < 0.01) in the peri- compared to the pre-COVID-19 period. These differences were more pronounced in HIV + patients. Compared to pre-COVID-19, the peri-COVID-19 period registered lower inpatient admissions but poorer treatment outcomes for general and HIV + inpatients. Emerging epidemic responses should minimize disruption to inpatient care, especially for HIV + individuals.
- Open Access
- 11 October 2022
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (10) , ofac541
Prevalence of Intestinal Helminth Coinfection in Drug-Resistant Tuberculosis in Uganda
Although a third of people with tuberculosis (TB) are estimated to be coinfected with helminths, the prevalence is largely unknown among people with drug-resistant TB (DR-TB). We determined the prevalence of helminth coinfection among people with DR-TB in Uganda. In a multicenter, cross-sectional study, eligible Ugandan adults with confirmed DR-TB were consecutively enrolled between July to December 2021 at 4 treatment centers. Sociodemographic data were collected using a questionnaire. Participants underwent anthropometric and blood pressure measurements, and blood samples were evaluated for random blood glucose, glycated hemoglobin, nonfasting lipid profile, human immunodeficiency virus (HIV) infection, and a complete blood count. Fresh stool samples were evaluated for adult worms, eggs, and larvae using direct microscopy after Kato-Katz concentration techniques. Of 212 participants, 156 (73.6%) were male, 118 (55.7%) had HIV, and 3 (2.8%) had malaria coinfection. The prevalence of intestinal helminth coinfection was 4.7% (10/212) (95% confidence interval, 2.6%–8.6%). The frequency of helminth infections was Ancylostoma duodenale (n = 4), Schistosoma mansoni (n = 2), Enterobius vermicularis (n = 2), Ascaris lumbricoides (n = 1), and Trichuris trichiura (n = 1). The prevalence of helminth coinfection was low among people with DR-TB. More studies are needed to determine the clinical relevance of helminth/DR-TB coinfection.
- 11 October 2022
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 9 (10) , ofac541
Open AccessPrevalence of Intestinal Helminth Coinfection in Drug-Resistant Tuberculosis in Uganda
Although a third of people with tuberculosis (TB) are estimated to be coinfected with helminths, the prevalence is largely unknown among people with drug-resistant TB (DR-TB). We determined the prevalence of helminth coinfection among people with DR-TB in Uganda. In a multicenter, cross-sectional study, eligible Ugandan adults with confirmed DR-TB were consecutively enrolled between July to December 2021 at 4 treatment centers. Sociodemographic data were collected using a questionnaire. Participants underwent anthropometric and blood pressure measurements, and blood samples were evaluated for random blood glucose, glycated hemoglobin, nonfasting lipid profile, human immunodeficiency virus (HIV) infection, and a complete blood count. Fresh stool samples were evaluated for adult worms, eggs, and larvae using direct microscopy after Kato-Katz concentration techniques. Of 212 participants, 156 (73.6%) were male, 118 (55.7%) had HIV, and 3 (2.8%) had malaria coinfection. The prevalence of intestinal helminth coinfection was 4.7% (10/212) (95% confidence interval, 2.6%–8.6%). The frequency of helminth infections was Ancylostoma duodenale (n = 4), Schistosoma mansoni (n = 2), Enterobius vermicularis (n = 2), Ascaris lumbricoides (n = 1), and Trichuris trichiura (n = 1). The prevalence of helminth coinfection was low among people with DR-TB. More studies are needed to determine the clinical relevance of helminth/DR-TB coinfection.